Dihydroartemisinin And Piperaquine Phosphate
Therapeutic Group
Anti-malarialsIndication Dosage
Dihydroartemisinin and Piperaquine Phosphate is a medication primarily prescribed for the treatment of uncomplicated Plasmodium falciparum malaria infections. This combination therapy is highly effective in rapidly clearing the malaria parasite from the bloodstream, relieving symptoms such as fever, chills, and fatigue, while also preventing the development of drug-resistant strains of the parasite.
Prophylaxis And Treatment Of Malaria:
- Adult & Children Above 6 Months: 7-13 Kg: Half Tab, 13-24 Kg: 1 Tab, 24-36 Kg: 2 Tab, 36-75 Kg: 3 Tab, 75-100 Kg: 4 Tab, Dose To Be Given Once Daily, 3 Hrs Before Or 3 Hrs After Food, For 3 Days. Max 2 Courses In 12 Months Separated By At Least 2 Months.
Content
- Cap /Tab: Dihydroartemisinin 40mg, PiPeraquine Phosphate 320mg.
- Sachet: Per Sachet: Dihydroartemisinin 15mg, PiPeraquine Phosphate 120mg.
Pregnancy
Contraindicated
Stability
- 4-piperazinoquinoline Derivative
- Artemisinin
Contra Indications
- History Of Arrhythmias, Of Clinical Relevant Bradycardia, And Of Congestive Heart Failure Accompanied By Reduced Ventricular Ejection Fraction; Family History Of Sudden Death Or Of Congenital Qt Interval Prolongation.
Precautions
- History Of Arrhythmias, Of Clinical Relevant Bradycardia, And Of Congestive Heart Failure Accompanied By Reduced Ventricular Ejection Fraction; Family History Of Sudden Death Or Of Congenital Qt Interval Prolongation.
Lactation
- Contraindicated
Side Effects
- Abdominal Pain
- Nausea
- Anorexia
- Diarrhoea
- Vomiting
- Headache
- Dizziness
- Asthenia
- Muscle Weakness And Pain
- Sleep Disturbances
- Nausea
- Palpitation
- Prolonged Qt Interval
- Cough
- Paresthesia
- Arthralgia
- Myalgia
- Pruritus
- Rash.